Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

BACKGROUND: Rifapentine-based regimens have potent antimycobacterial activity that may allow for a shorter course in patients with drug-susceptible pulmonary tuberculosis. METHODS: In an open-label, phase 3, randomized, controlled trial involving persons with newly diagnosed pulmonary tuberculosis f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:N Engl J Med
Hauptverfasser: Dorman, Susan E., Nahid, Payam, Kurbatova, Ekaterina V., Phillips, Patrick P.J., Bryant, Kia, Dooley, Kelly E., Engle, Melissa, Goldberg, Stefan V., Phan, Ha T.T., Hakim, James, Johnson, John L., Lourens, Madeleine, Martinson, Neil A., Muzanyi, Grace, Narunsky, Kim, Nerette, Sandy, Nguyen, Nhung V., Pham, Thuong H., Pierre, Samuel, Purfield, Anne E., Samaneka, Wadzanai, Savic, Radojka M., Sanne, Ian, Scott, Nigel A., Shenje, Justin, Sizemore, Erin, Vernon, Andrew, Waja, Ziyaad, Weiner, Marc, Swindells, Susan, Chaisson, Richard E.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2021
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8282329/
https://ncbi.nlm.nih.gov/pubmed/33951360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2033400
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge